GHRS
GH Research PLC
Price Chart
Latest Quote
$23.61
+1.52 (+6.88%)
Current Price
| Previous Close | $22.09 |
| Open | $21.75 |
| Day High | $24.36 |
| Day Low | $21.44 |
| Volume | 299,569 |
Stock Information
| Shares Outstanding | 68.61M |
| Total Debt | $432K |
| Cash Equivalents | $267.32M |
| Net Income | $-56.41M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $1.62B |
| EPS (TTM) | $-0.91 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.20B |
| Income | $-56.41M |
| Book/sh | $4.25 |
| Cash/sh | $3.90 |
| Employees | 73 |
Financial Ratios
| Quick Ratio | 22.63 |
| Current Ratio | 23.04 |
| Debt/Eq | 0.16 |
Returns & Margins
| ROA | -13.99% |
| ROE | -19.67% |
Ownership
| Insider Ownership | 24.23% |
| Institutional Ownership | 70.22% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -11.81 |
| P/B | 5.56 |
Analyst Data
| Recommendation | none |
| Target Price | $39.50 |
Technical Indicators
| SMA20 | $22.16 |
| SMA50 | $21.11 |
| SMA200 | $16.05 |
| RSI | 44.18 |
| ATR | 1.7266 |
| Shares Float | 26.72M |
| Short Float | 8.19% |
| Short Ratio | 9.81 |
| Volatility | 1.31 |
| Rel Volume | 1.05 |
Performance History
| Week | +15.91% |
| Month | +8.45% |
| Quarter | +78.73% |
| 6 Months | +85.61% |
| YTD | +78.32% |
| Year | +91.80% |
| 3 Years | +95.93% |
| 10 Years | +22.65% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $23.61 | 299,569 |
| 2026-06-22 | $22.09 | 763,100 |
| 2026-06-18 | $22.24 | 544,600 |
| 2026-06-17 | $21.70 | 178,600 |
| 2026-06-16 | $19.98 | 133,500 |
| 2026-06-15 | $20.37 | 159,500 |
| 2026-06-12 | $21.12 | 181,100 |
| 2026-06-11 | $20.66 | 220,000 |
| 2026-06-10 | $20.36 | 140,700 |
| 2026-06-09 | $20.35 | 270,700 |
| 2026-06-08 | $20.12 | 379,100 |
| 2026-06-05 | $21.43 | 351,900 |
| 2026-06-04 | $23.25 | 282,700 |
| 2026-06-03 | $24.43 | 141,000 |
| 2026-06-02 | $24.87 | 381,900 |
| 2026-06-01 | $24.83 | 286,300 |
| 2026-05-29 | $23.99 | 318,400 |
| 2026-05-28 | $22.38 | 122,100 |
| 2026-05-27 | $22.36 | 223,100 |
| 2026-05-26 | $23.15 | 337,700 |
About GH Research PLC
GH Research PLC, together with its subsidiary, operates a clinical-stage biopharmaceutical company that develops treatments for depression in the United States. The company's lead product candidate is GH001, an inhalable mebufotenin product candidate that is in Phase 2b clinical trial for treating patients with treatment-resistant depression and in Phase 2a clinical trials for treating bipolar II disorder and postpartum depression. It also develops GH002, an intravenous mebufotenin product candidate, which is in phase 1 clinical pharmacology trial in healthy volunteers focusing on psychiatric and neurological disorders. The company was founded in 2018 and is based in Dublin, Ireland.
đ° Latest News
H.C. Wainwright Maintains Buy Rating on GH Research (GHRS)
Insider Monkey âĸ 2026-06-05T21:03:45Z
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Market Exclusive âĸ 2026-05-18T14:03:51ZAssessing GH Research (GHRS) Valuation After Key Phase 2b Results And Phase 3 Trial Plans
Simply Wall St. âĸ 2026-05-16T20:12:06Z
FDA Fast-Tracks Review of Some Psychedelic Drugs. This Stock Is Set to Benefit.
Barrons.com âĸ 2026-04-24T20:12:00Z
FDA Fast-Tracks Psychedelic Drug Research Following Trump Directive; Psychedelic Drug Makers Gain
MT Newswires âĸ 2026-04-24T14:19:44ZâCan I have some, please?â: Trump jokes as he signs psychedelics order after Joe Rogan push. These stocks soar
Moneywise âĸ 2026-04-22T12:49:00Z
How Trump Sent Psychedelics-Tied Compass Pathways And Others Flying
Investor's Business Daily âĸ 2026-04-20T20:26:11Z
Sector Update: Health Care Stocks Fall Late Afternoon
MT Newswires âĸ 2026-04-20T19:55:23ZMarket Feels Weak, But Stocks Tell Stories
GuruFocus.com âĸ 2026-04-20T18:34:07ZTrump Pushes for Speedy Psychedelic Approvals, Sending Stocks Surging
The Wall Street Journal âĸ 2026-04-20T15:48:51Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $35,000 | $48,000 | $63,000 | $0 |
| Total Expenses | $60,676,000 | $50,246,000 | $41,221,000 | $30,675,000 |
| Other Income Expense | $7,799,000 | $5,727,000 | $329,000 | $7,484,000 |
| Net Non Operating Interest Income Expense | $4,619,000 | $5,558,000 | $5,305,000 | $735,000 |
| Total Other Finance Cost | $428,000 | $669,000 | $660,000 | $123,000 |
| Interest Expense Non Operating | $35,000 | $48,000 | $63,000 | $0 |
| Operating Expense | $60,676,000 | $50,246,000 | $41,221,000 | $30,675,000 |
| General And Administrative Expense | $21,651,000 | $15,002,000 | $11,121,000 | $10,056,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-48,258,000 | $-38,961,000 | $-35,587,000 | $-22,456,000 |
| Net Interest Income | $4,619,000 | $5,558,000 | $5,305,000 | $735,000 |
| Interest Income | $5,082,000 | $6,275,000 | $6,028,000 | $858,000 |
| Normalized Income | $-56,057,000 | $-44,688,000 | $-35,916,000 | $-29,940,000 |
| Net Income From Continuing And Discontinued Operation | $-48,258,000 | $-38,961,000 | $-35,587,000 | $-22,456,000 |
| Total Operating Income As Reported | $-60,718,000 | $-50,312,000 | $-41,222,000 | $-30,554,000 |
| Net Income Common Stockholders | $-48,258,000 | $-38,961,000 | $-35,587,000 | $-22,456,000 |
| Net Income | $-48,258,000 | $-38,961,000 | $-35,587,000 | $-22,456,000 |
| Net Income Including Noncontrolling Interests | $-48,258,000 | $-38,961,000 | $-35,587,000 | $-22,456,000 |
| Net Income Continuous Operations | $-48,258,000 | $-38,961,000 | $-35,587,000 | $-22,456,000 |
| Pretax Income | $-48,258,000 | $-38,961,000 | $-35,587,000 | $-22,456,000 |
| Interest Income Non Operating | $5,082,000 | $6,275,000 | $6,028,000 | $858,000 |
| Operating Income | $-60,676,000 | $-50,246,000 | $-41,221,000 | $-30,675,000 |
| Depreciation Amortization Depletion Income Statement | $302,000 | $294,000 | $280,000 | $14,000 |
| Depreciation And Amortization In Income Statement | $302,000 | $294,000 | $280,000 | $14,000 |
| Depreciation Income Statement | $302,000 | $294,000 | $280,000 | $14,000 |
| Per Share | ||||
| Diluted EPS | $-0.79 | $-0.75 | $-0.68 | $-0.43 |
| Basic EPS | $-0.79 | $-0.75 | $-0.68 | $-0.43 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-55,687,000 | $-44,325,000 | $-35,538,000 | $-29,893,000 |
| Total Unusual Items | $7,799,000 | $5,727,000 | $329,000 | $7,484,000 |
| Total Unusual Items Excluding Goodwill | $7,799,000 | $5,727,000 | $329,000 | $7,484,000 |
| Reconciled Depreciation | $335,000 | $315,000 | $315,000 | $47,000 |
| EBITDA (Bullshit earnings) | $-47,888,000 | $-38,598,000 | $-35,209,000 | $-22,409,000 |
| EBIT | $-48,223,000 | $-38,913,000 | $-35,524,000 | $-22,456,000 |
| Diluted Average Shares | $61,042,621 | $51,948,000 | $52,333,824 | $52,020,849 |
| Basic Average Shares | $61,042,621 | $51,948,000 | $52,333,824 | $52,020,849 |
| Diluted NI Availto Com Stockholders | $-48,258,000 | $-38,961,000 | $-35,587,000 | $-22,456,000 |
| Tax Provision | $0 | $0 | $0 | $0 |
| Gain On Sale Of Security | $7,799,000 | $5,727,000 | $329,000 | $7,484,000 |
| Provision For Doubtful Accounts | $-42,000 | $-66,000 | $-1,000 | $121,000 |
| Research And Development | $38,765,000 | $35,016,000 | $29,821,000 | $20,484,000 |
| Selling General And Administration | $21,651,000 | $15,002,000 | $11,121,000 | $10,056,000 |
| Other Gand A | $12,956,000 | $10,182,000 | $7,692,000 | $7,785,000 |
| Salaries And Wages | $8,695,000 | $4,820,000 | $3,429,000 | $2,271,000 |
Fetched: 2026-06-18
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $279,703,000 | $178,951,000 | $218,968,000 | $249,816,000 |
| Total Assets | $288,230,000 | $188,273,000 | $226,300,000 | $254,362,000 |
| Total Non Current Assets | $2,254,000 | $34,048,000 | $62,211,000 | $85,821,000 |
| Non Current Accounts Receivable | $1,634,000 | - | - | - |
| Investmentin Financial Assets | $0 | $33,300,000 | $61,142,000 | $85,724,000 |
| Current Assets | $285,976,000 | $154,225,000 | $164,089,000 | $168,541,000 |
| Prepaid Assets | $3,973,000 | $3,169,000 | $2,232,000 | $2,449,000 |
| Receivables | $1,295,000 | $1,732,000 | $297,000 | $90,000 |
| Other Receivables | $1,158,000 | $1,582,000 | $119,000 | - |
| Taxes Receivable | $137,000 | $150,000 | $178,000 | $90,000 |
| Cash Cash Equivalents And Short Term Investments | $280,708,000 | $149,324,000 | $161,560,000 | $165,955,000 |
| Cash And Cash Equivalents | $246,251,000 | $100,791,000 | $78,420,000 | $165,955,000 |
| Cash Equivalents | $215,279,000 | $72,214,000 | $37,030,000 | $35,703,000 |
| Cash Financial | $30,972,000 | $28,577,000 | $41,390,000 | $130,252,000 |
| Other Current Assets | - | $1,582,000 | $119,000 | $47,000 |
| Debt | ||||
| Total Debt | $512,000 | $624,000 | $974,000 | $0 |
| Long Term Debt And Capital Lease Obligation | $147,000 | $369,000 | $631,000 | $0 |
| Current Debt And Capital Lease Obligation | $365,000 | $255,000 | $343,000 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $8,527,000 | $9,322,000 | $7,332,000 | $4,546,000 |
| Total Non Current Liabilities Net Minority Interest | $147,000 | $369,000 | $631,000 | $0 |
| Current Liabilities | $8,380,000 | $8,953,000 | $6,701,000 | $4,546,000 |
| Other Current Liabilities | $407,000 | $704,000 | $203,000 | $95,000 |
| Payables And Accrued Expenses | $7,608,000 | $7,994,000 | $6,155,000 | $4,451,000 |
| Payables | $4,268,000 | $4,126,000 | $3,830,000 | $2,085,000 |
| Other Payable | $495,000 | $385,000 | $340,000 | $217,000 |
| Accounts Payable | $3,773,000 | $3,741,000 | $3,490,000 | $1,868,000 |
| Equity | ||||
| Common Stock Equity | $279,703,000 | $178,951,000 | $218,968,000 | $249,816,000 |
| Total Equity Gross Minority Interest | $279,703,000 | $178,951,000 | $218,968,000 | $249,816,000 |
| Stockholders Equity | $279,703,000 | $178,951,000 | $218,968,000 | $249,816,000 |
| Gains Losses Not Affecting Retained Earnings | $1,516,000 | $-7,367,000 | $-5,856,000 | $-10,440,000 |
| Other Equity Adjustments | $13,292,000 | $5,194,000 | $4,651,000 | $2,595,000 |
| Retained Earnings | $-154,425,000 | $-106,446,000 | $-67,940,000 | $-32,493,000 |
| Other | ||||
| Ordinary Shares Number | $62,029,395 | $52,028,145 | $52,028,145 | $52,020,849 |
| Share Issued | $62,029,395 | $52,028,145 | $52,028,145 | $52,020,849 |
| Tangible Book Value | $279,703,000 | $178,951,000 | $218,968,000 | $249,816,000 |
| Invested Capital | $279,703,000 | $178,951,000 | $218,968,000 | $249,816,000 |
| Working Capital | $277,596,000 | $145,272,000 | $157,388,000 | $163,995,000 |
| Capital Lease Obligations | $512,000 | $624,000 | $974,000 | $0 |
| Total Capitalization | $279,703,000 | $178,951,000 | $218,968,000 | $249,816,000 |
| Foreign Currency Translation Adjustments | $-11,776,000 | $-12,561,000 | $-10,507,000 | $-13,035,000 |
| Additional Paid In Capital | $431,061,000 | $291,463,000 | $291,463,000 | $291,448,000 |
| Capital Stock | $1,551,000 | $1,301,000 | $1,301,000 | $1,301,000 |
| Common Stock | $1,551,000 | $1,301,000 | $1,301,000 | $1,301,000 |
| Long Term Capital Lease Obligation | $147,000 | $369,000 | $631,000 | $0 |
| Current Capital Lease Obligation | $365,000 | $255,000 | $343,000 | $0 |
| Current Accrued Expenses | $3,340,000 | $3,868,000 | $2,325,000 | $2,366,000 |
| Investments And Advances | $0 | $33,300,000 | $61,142,000 | $85,724,000 |
| Net PPE | $620,000 | $748,000 | $1,069,000 | $97,000 |
| Accumulated Depreciation | $-1,063,000 | $-635,000 | $-389,000 | $-66,000 |
| Gross PPE | $1,683,000 | $1,383,000 | $1,458,000 | $163,000 |
| Other Properties | $1,683,000 | $1,383,000 | $1,234,000 | $36,000 |
| Other Short Term Investments | $34,457,000 | $48,533,000 | $83,140,000 | $0 |
| Available For Sale Securities | - | $33,300,000 | $61,142,000 | $85,724,000 |
| Machinery Furniture Equipment | - | $257,000 | $224,000 | $127,000 |
Fetched: 2026-06-18
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-43,673,000 | $-42,334,000 | $-33,436,000 | $-26,266,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-43,552,000 | $-42,285,000 | $-33,336,000 | $-26,199,000 |
| Cash Flow From Continuing Operating Activities | $-43,552,000 | $-42,285,000 | $-33,336,000 | $-26,199,000 |
| Operating Gains Losses | $-1,753,000 | $-2,129,000 | $2,621,000 | $-7,176,000 |
| Investing Activities | ||||
| Capital Expenditure | $-121,000 | $-49,000 | $-100,000 | $-67,000 |
| Investing Cash Flow | $46,172,000 | $65,135,000 | $-54,100,000 | $-84,688,000 |
| Cash Flow From Continuing Investing Activities | $46,172,000 | $65,135,000 | $-54,100,000 | $-84,688,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $150,000,000 | $0 | $15,000 | $0 |
| Financing Cash Flow | $139,651,000 | $-304,000 | $-204,000 | $0 |
| Cash Flow From Continuing Financing Activities | $139,651,000 | $-304,000 | $-204,000 | $0 |
| Net Other Financing Charges | $-10,152,000 | - | - | - |
| Net Common Stock Issuance | $150,000,000 | $0 | $15,000 | $0 |
| Common Stock Issuance | $150,000,000 | $0 | $15,000 | $0 |
| Other | ||||
| Repayment Of Debt | $-197,000 | $-304,000 | $-219,000 | $0 |
| End Cash Position | $246,251,000 | $100,791,000 | $78,420,000 | $165,955,000 |
| Beginning Cash Position | $100,791,000 | $78,420,000 | $165,955,000 | $276,776,000 |
| Effect Of Exchange Rate Changes | $3,189,000 | $-175,000 | $105,000 | $66,000 |
| Changes In Cash | $142,271,000 | $22,546,000 | $-87,640,000 | $-110,887,000 |
| Net Issuance Payments Of Debt | $-197,000 | $-304,000 | $-219,000 | $0 |
| Net Long Term Debt Issuance | $-197,000 | $-304,000 | $-219,000 | $0 |
| Long Term Debt Payments | $-197,000 | $-304,000 | $-219,000 | $0 |
| Net Investment Purchase And Sale | $46,293,000 | $65,184,000 | $-54,000,000 | $-84,621,000 |
| Sale Of Investment | $46,293,000 | $65,184,000 | $0 | $0 |
| Purchase Of Investment | $0 | $0 | $-54,000,000 | $-84,621,000 |
| Net PPE Purchase And Sale | $-121,000 | $-49,000 | $-100,000 | $-67,000 |
| Purchase Of PPE | $-121,000 | $-49,000 | $-100,000 | $-67,000 |
| Interest Received Cfo | $12,060,000 | $7,076,000 | $4,283,000 | $500,000 |
| Interest Paid Cfo | $-639,000 | $-723,000 | $-648,000 | $-22,000 |
| Change In Working Capital | $-3,094,000 | $188,000 | $1,645,000 | $2,159,000 |
| Other Non Cash Items | $-10,665,000 | $-9,156,000 | $-8,255,000 | $-1,043,000 |
| Stock Based Compensation | $8,504,000 | $1,171,000 | $2,291,000 | $1,671,000 |
| Provisionand Write Offof Assets | $-42,000 | $-66,000 | $-1,000 | $121,000 |
| Depreciation Amortization Depletion | $335,000 | $315,000 | $315,000 | $47,000 |
| Depreciation And Amortization | $335,000 | $315,000 | $315,000 | $47,000 |
| Depreciation | $335,000 | $315,000 | $315,000 | $47,000 |
| Net Foreign Currency Exchange Gain Loss | $-1,753,000 | $-2,129,000 | $2,621,000 | $-7,176,000 |
| Net Income From Continuing Operations | $-48,258,000 | $-38,961,000 | $-35,587,000 | $-22,456,000 |
Fetched: 2026-06-18